Invention Grant
- Patent Title: Strain for the treatment and/or prevention of chronic inflammatory diseases
-
Application No.: US14901154Application Date: 2014-06-24
-
Publication No.: US09750774B2Publication Date: 2017-09-05
- Inventor: Patrick Taillade , Maria Urdaci
- Applicant: LESAFFRE ET COMPAGNIE , ECOLE NATIONALE SUPERIEURE DES SCIENCES AGRONOMIQUES DE BORDEAUX AQUITAINE (BORDEAUX SCIENCES AGRO)
- Applicant Address: FR Paris FR Gradignan
- Assignee: LESAFFRE ET COMPAGNIE,ECOLE NATIONALE SUPERIEURE DES SCIENCES AGRONOMIQUES DE BORDEAUX AQUITAINE (BORDE AUX SCIENCES AGRO)
- Current Assignee: LESAFFRE ET COMPAGNIE,ECOLE NATIONALE SUPERIEURE DES SCIENCES AGRONOMIQUES DE BORDEAUX AQUITAINE (BORDE AUX SCIENCES AGRO)
- Current Assignee Address: FR Paris FR Gradignan
- Agency: Vedder Price P.C.
- Agent Thomas J. Kowalski; Deborah L. Lu
- Priority: FR1356274 20130628
- International Application: PCT/FR2014/051561 WO 20140624
- International Announcement: WO2014/207360 WO 20141231
- Main IPC: A61K35/742
- IPC: A61K35/742 ; A23L33/135 ; A61K35/00
Abstract:
The present invention concerns the probiotic strain Bacillus subtilis CU1 filed with the French Collection Nationale de Culture des Microorganismes (National Collection of Microorganism Cultures) under number I-2745, cells obtained by culturing said strain and a composition comprising cells obtained by culturing said strain, for the use thereof in the treatment and/or prevention of chronic inflammatory diseases, and in particular chronic inflammatory rheumatism.
Public/Granted literature
- US20160136209A1 STRAIN FOR THE TREATMENT AND/OR PREVENTION OF CHRONIC INFLAMMATORY DISEASES Public/Granted day:2016-05-19
Information query
IPC分类:
